As of June 2026 BioMarin Pharmaceutical has a market cap of HK$83.31 Billion. This makes BioMarin Pharmaceutical the world's 1952th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jun 16th, 2026 the market cap of BioMarin Pharmaceutical was reported to be: